Pharma & Biotech

IO Biotech's stock continues its downward trajectory, with Monday's 12 percent plunge signaling further volatility ahead. The company confronts a...

All attention turns to Tandem Diabetes Care as the medical device company prepares to release its third-quarter 2025 financial results...

All attention turns to Pacific Biosciences today as the biotechnology firm prepares to release its third-quarter financial results after market...

Investors are closely monitoring Trevi Therapeutics (TRVI) as the biopharmaceutical company prepares to release its third-quarter 2025 financial results this...

A small biotechnology company is capturing significant market attention as industry experts identify substantial growth potential in its innovative cancer...

The biotechnology sector was rattled by an unexpected development yesterday. In a move that caught investors off guard, Goldman Sachs...

After a period of underperformance, Cellectar Biosciences shares are displaying initial signs of recovery. This comes at a time when...

The battle for dominance in the lucrative weight-loss medication sector has entered a critical new phase. Pharmaceutical giant Pfizer has...

Investor attention is firmly fixed on Assembly Biosciences as the biotechnology firm prepares to release its third-quarter financial results. Following...

Thermo Fisher Scientific, a global leader in life sciences, has announced a transformative $8.9 billion acquisition that underscores its ambitious...